Elevate Movement

Elevate Movement

Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Funding information not available

Overview

Elevate Movement is a private, commercial-stage medical device company founded in 2019 and headquartered in Carlsbad, California (with a listed San Francisco origin). It operates in the digital health sector, specifically within the orthopedic bracing market for drop foot. The company's core business involves the design, fabrication, and direct-to-clinic sale of proprietary AFOs, leveraging advanced carbon fiber manufacturing and a swift customization service. It appears to be in an early revenue-generating phase, building its market presence through clinician partnerships and patient community engagement.

Neurological DisordersOrthopedics

Technology Platform

Proprietary compression-molded carbon fiber manufacturing process for creating durable, high-strength, and aesthetically designed Ankle-Foot Orthoses (AFOs). Platform includes the Swift System for rapid custom fabrication.

Opportunities

The growing global market for mobility aids, driven by an aging population and rising neurological conditions, presents a significant expansion opportunity.
Elevate can leverage its advanced carbon fiber technology and rapid service model to capture share from traditional, less aesthetic orthotics and potentially expand into adjacent mobility impairment segments.

Risk Factors

Key risks include slow adoption by conservative clinical prescribers, complex and variable insurance reimbursement landscapes for durable medical equipment, and dependence on a single manufacturing partner for its core carbon fiber technology, creating supply chain vulnerability.

Competitive Landscape

Elevate competes in the ankle-foot orthosis market against large established medical device companies (e.g., Ottobock, DJO Global) and numerous smaller orthotic labs. Its differentiation is based on high-design carbon fiber construction, rapid customization turnaround, and a direct-to-clinic commercial model emphasizing partnership and education.